Schlagwort-Archive: lps

Does Acinetobacter lwoffii F78 protect from allergy?

When reading a new Science immunology paper (“Inception of early-life allergen-induced airway hyperresponsiveness is reliant on IL-13+CD4+T cells“) one could again think that A. lwoffii could protect from the development of house mite allergy.

The paper, however, leaves it open (even doesn’t mention the result in the discussion) if this is any specific A. lwofii effect or just some some LPS  effect that antagonized the vitamin D containing food.

So no news even 10 years  after the initial Acinetobacter hype. The only verified fact remain several deaths caused by Acinetobacter in newborns.

A factor in hay prevents vitamin D action

As always, a longer literature search prevents from new discoveries… Here comes a nice piece from 1952 on the antagonistic effect of LPS on vitamin D (Is that really LPS or did I interpret it wrong?). Although not included in my recent review on vitamin D and allergy – I attributed the effect to Lyakh et al. – here is the first description of this effect. A factor in hay prevents vitamin D action weiterlesen

Severe flaw in mouse allergy studies

A report in Biospektrum 07.07/13:762 about the production of endotoxin free ovalbumin by a German company now reveals that nearly all commercially available ovalbumin preparations are highly contaminated with endotoxin. Company A included 723, company B 1038, company C 257 and company D 342 EU/mg LPS. As all mice are usually also on a vitamin D supplement diet, recent mouse studies may have produced largely artifacts if both – agonist and antagonist – are included in an uncontrolled manner, yea, yea.

Auto desensitization

Blackley found already in 1873 an interesting explanation of the “no allergy in farming children” effect by referring to some kind of auto desensitization in this particular environment – e.g. the high pollen and LPS exposure.
Do you know that a commercial allergen preparation used for desensitization already includes a LPS derivate, 3-o-desacyl-4′ monophosphoryl lipid A as an adjuvant? It is believed to push the pollen reaction into a IL12 – IFNg – Th1 pathway. This therapeutic approach already perfectly fits the early explanation of Blackley.
When will the allergy farming lobby ultimately close their files?